protective. In the present study, the protective abilities of purified extracts obtained from a virulent and an avirulent strain of S. enteritidis with sodium dodecyl sulfate or sodium deoxycholate (16) are compared with those produced by living or dead whole-cell vaccines MATERIALS AND METHODS Organism. S. enteritidis (NCTC 5694) was obtained from Collindale, England. This organism had an intravenous LD50 of 10 organisms.
Vaccines. Whole cells, cell walls, and cell wall extracts of S. enteritidis (strain Se795) were prepared as described in an earlier paper (15) . Lipopolysaccharide was prepared by the method of Westphal et al. (19) . All vaccines were tested for sterility as described elsewhere (Collins et al., J. Exptl. Med., in press). Cell wall vaccines were suspended in 70% ethyl alcohol at 4 C overnight. The walls were centrifuged at 20,000 X g for 30 min, resuspended in sterile saline, and diluted to contain 1 mg (dry weight) per ml.
Sodium deoxycholate and sodium dodecyl sulfate primary extracts and the separated fractions were dissolved in sterile saline at a concentration of 1.0 mg (dry weight) per rml. The resulting opalescent solutions were sterilized by passage through a membrane filter (pore size, 0.45 ,A, Millipore). Sterility tests were COLLINS AND MILNE carried out on five 1.0-ml samples. The vaccines were dispensed in 2.0-ml samples. These were stored at -20 C until required, used once, and then discarded.
Vaccination programs. All vaccines were diluted to the required strength and injected within 60 min. Swiss-Webster white mice (18 to 24 g) were used throughout. Doses of the whole bacterial vaccines started with three injections of 106 bacteria per mouse per week, rose to 107, and rose again to 108 in subsequent weeks. The mice were then rested for 7 days. Prior to challenge, a number of mice from each group were randomly selected; their livers and spleens were removed and homogenized in broth. The homogenates were incubated and examined for S. enteritidis to establish the sterility of the vaccines used for immunization. Doses of cell walls and the various purified fractions were graded so that the amount injected was equivalent on a weight-for-weight basis with the calculated amount of antigenic material present in the original whole cells. All the vaccinated mice, together with groups of normal mice of the same age, were challenged intravenously (iv) with 1,000 LD50 of S. enteritidis. The numbers of organisms in the livers, spleens, and blood of five randomly selected mice were estimated after 1 hr and at daily intervals after challenge by the method described by Mackaness et al. (J. Exptl. Med., in press). A group of mice were always put aside so that the progressive number of deaths in immunized and control mice could be compared.
RESULTS
Mouse-protection tests were carried out to compare the "protective" value of the dodecyl sulfate and the deoxycholate extracts obtained from the virulent and avirulent strains of S. enteritidis (15) . Protection was assessed on the basis of the ability of the immunized mice to inhibit the in vivo growth of the challenge organism, as well as by the actual survival of a higher proportion of treated mice.
Protection of mice immunized with the primary dodecyl sulfate extracts. Intravenous challenge of mice immunized with extracts prepared from virulent or avirulent S. enteritidis was characterized by a rapid clearance ofthe organisms from the blood with an average recovery of only 5 to 10% of the inoculum as viable organisms in the liver and spleen after 1 hr (Fig. 1) . Growth of the challenge organism in the spleen and liver of mice immunized with extracts prepared from either virulent or avirulent strains was essentially identical.
On the other hand, normal control mice often failed to clear the blood by the end of 60 min. The blood-borne population was sufficiently high to account for up to 10% of the challenge organisms injected 1 hr previously. At the same time, the liver and spleen population represented 50% or more of the initial challenge dose (Fig. 6) . Basically, this was the only significant difference between the behavior of the organism in the normal and in the vaccinated mice. In the control mice, the liver and spleen populations rose rapidly to an average of 108 by the 3rd day, at which time deaths began to occur. By day 14, all unvacci-able to generate sufficient response in the host to nated mice were dead (Table 1 ). The mortality of prevent the growth of the challenge organism, or the vaccinated mice was 55 to 85% of that ob-even to reduce substantially the severity of the served in controls. However, from the liver and infection. spleen populations present from day 2 onwards, When mice were immunized with the separate it was obvious that none of the extracts had been fractions, the growth curves shown in Fig. 2 were obtained. Clearly, only the first fraction obtained by elution of both the virulent and avirulent cell extracts from the diethylaminoethyl (DEAE) cellulose had any influence on the in vivo growth of the challenge organism, an effect reflected in the survival data recorded in Table 1 . Tests of the later fractions showed that, although these were also capable of producing antibodies which resulted in rapid blood clearance, they were unable to influence the subsequent course of the infection. With the failure to show any real protection from the dodecyl sulfate extracts, attention was turned to the deoxycholate extracts to see whether they were any more effective as immunizing agents.
Protection of mice immunized with the deoxycholate extracts. The growth of S. enteritidis after iv challenge of mice immunized with deoxycholate extracts of the virulent and avirulent strains is recorded in Fig. 3 . The curves are comparable in every respect with those obtained with the dodecyl sulfate extracts. The survival data in Table 2 shows that up to 45% of the mice survived the challenge, but the in vivo growth data indicates again that immunization contributed little or nothing to the host's capacity to influence the ultimate size of the infecting population. The purified deoxycholate fractions behaved in a similar manner to the dodecyl sulfate extracts. Only the first DEAE cellulose fraction, from either virulent or avirulent organisms, influenced the growth rate of S. enteritidis in vivo (Fig. 4, Table 2 ). 5-a E The poor protection obtained in the present study was conceivably due to the destruction of the "protective" antigens during the extraction process. To determine whether this had in fact occurred, and also to place the above results in a better perspective, mice were immunized with a living vaccine of an avirulent strain and also with an alcohol-killed vaccine consisting of whole cells of the virulent strain of S. enteritidis.
Protection of mice immunized with whole-cell vaccines. Mice were immunized by the iv injection of 105 living S. enteritidis (streptomycin-resistant). Twenty-eight days later, the survivors were found to be completely resistant to 1,000 LD50 of the virulent organism (Table 1) . Enumeration of both the challenge and vaccinating organisms in the livers and spleens of these mice revealed a rapid and complete elimination of the reinfecting organisms so that, by 4 days, only the residual vaccinating strain could be detected (Fig. 5) .
After repeated injections of alcohol-killed whole cells, an iv challenge with 100 LD50 of S. enteritidis killed 80% of vaccinated mice compared with 100% of the controls (Table 1) . Enumeration of the liver, spleen, and blood populations in these mice showed that immunization with dead organisms had enhanced blood clearance and temporarily delayed the rise in liver and spleen populations (Fig. 6 ). This effect was entirely comparable with that already observed after immunization with the most effective of the bacterial extracts. The failure of bacterial extracts 
FIG. 4.
Average liver and spleen populations ofSalmonella enteritidis after iv challenge ofmice immunized with separate fractions prepared from the primary deoxycholate extracts. Symbols: 0 = normal control; = SDC virulent strain peak I and SDC avirulent strain peak 1; A = SDC virulent strain peaks 2 and 3; V = SDC avirulent strain peak 2. The high-speed deposit vaccinated mice had a growth curve similar to the avirulent peak 2 mice.
to protect mice could not, therefore, be explained by the destruction of "protective" antigens during the extraction procedure. The survivors from the above protection experiment were challenged again, this time with 1,000 LD50 of a virulent streptomycin-resistant strain of S. enteritidis. Liver and spleen enumeration showed that the reinfecting population was rapidly and completely inactivated (Fig. 7) . This enteritidis were also unsuccessful (15) . Furthermore, it was not possible to demonstrate any significant differences in the immunogenicity of extracts prepared from the two strains. It is possible, however, that the tests employed were capable of detecting only gross differences in inmmunogenicity. The only heat-labile antigen shown to give any increase in resistance was found in the first fraction eluted from the DEAE cellulose column. This was true regardless of which organism or extractant was employed. However, the interpretation of these results is critically dependent on the criteria used to assess protection. If only the progressive mortality figures and the mean time to death are taken into account, immunization with any of the primary extracts, or with the material in the first DEAE cellulose fractions, gave significant protection. On the basis of percentage mortality, these extracts were comparable in their "protective" ability to to the dodecyl sulfate extracts obtained from S. typhimurium (11) . However, when the growth of the challenge organism was followed each day in the liver, spleen, and blood of randomly selected animals, a different picture emerged. The best that could be achieved in mice immunized either with whole dead cells, or the most active extracts, was a rapid and complete clearing of the blood and a 24-to 48-hr delay in the growth of organisms in the liver and spleen. Thereafter, rapid growth occurred until a maximum of 108 to 109 organisms was reached. At this time, death usually intervened. In the groups of animals showing "significant" protection, there was a 48-hr delay before any significant increase in bacterial numbers was observed in spleen and liver. Thereafter, the rate of bacterial growth in normal and vaccinated animals was similar. However, this initial delay meant that the maximal bacterial populations were not reached until 6 to The present results are entirely consistent with this view. However, the increased resistance of mice immunized with killed S. enteritidis vaccines to the toxic effects of killed whole cells, or purified lipopolysaccharide, points to an antitoxic role for the antibodies produced in response to the injection of dead vaccines. The exact mechanism of endotoxin tolerance has been the subject of some controversy (3, 4, 6, 7, 12) , and evidence for the participation of both humoral and cellular factors has been adduced. Recently, however, there has been an increasing body of evidence to suggest that resistance to the biological effects of endotoxin depends largely upon specific neutralization of the lipopolysaccharide moiety by humoral factors (14) . It is possible, therefore, that, in the present studies, the specific neutralization of the endotoxin by humoral antibody could explain the survival of a proportion of vaccinated animals despite the presence in the liver and spleen of bacteria in sufficient numbers to insure the death of unvaccinated mice.
If antibody plays such a relatively minor role in the course of the infection, it seems hardly surprising that the present attempts to isolate a "protective" antigen from S. enteritidis failed so consistently. Thus, although the heat-labile antigens of the salmonellae remain of considerable academic and taxonomic interest, they do not appear to determine the virulence of S. enteritidis so far as the mouse is concerned. There seems, therefore, little point to further attempts at isolating and purifying these antigens as a means of studying the immune response to this organism. Investigation of the cellular changes associated with the use of living vaccines would appear to be a more attractive line of approach to this problem.
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